Dosing strategies for switching from oral risperidone to paliperidone palmitate: Effects on clinical outcomes

INTRODUCTION: There are currently no guidelines for switching patients from oral risperidone to paliperidone palmitate (Invega Sustenna®). Furthermore, the paliperidone long-acting injectable (LAI) package insert does not recommend bridging with oral antipsychotics, which may result in inadequate se...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ment Health Clin
Main Authors: Hsia, Stephanie L., Leckband, Susan G., Rao, Sanjai, Jackson, Elizabeth, Lacro, Jonathan P.
Format: Artigo
Jezik:Inglês
Izdano: College of Psychiatric & Neurologic Pharmacists 2018
Teme:
Innovative Practices
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007563/
https://ncbi.nlm.nih.gov/pubmed/29955505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2017.05.095
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki